首页> 外文期刊>Research and practice in thrombosis and haemostasis. >Respective roles of Glycoprotein VI and FcγRIIA in the regulation of αIIbβ3-mediated platelet activation to fibrinogen, thrombus buildup, and stability
【24h】

Respective roles of Glycoprotein VI and FcγRIIA in the regulation of αIIbβ3-mediated platelet activation to fibrinogen, thrombus buildup, and stability

机译:糖蛋白VI和FcγRIIA在αiibβ3介导的血小板活化调控中的各自作用对纤维蛋白原,血栓累积和稳定性

获取原文
           

摘要

Background The interplay between platelets and fibrinogen is the cornerstone of thrombus formation. Integrin αIIbβ3 is the main platelet adhesion receptor for fibrinogen and mediates an outside-in signal upon ligand binding that reinforces platelet activation. In addition, FcγRIIA and glycoprotein VI (GPVI) contribute to platelet activation on fibrinogen, thereby participating in thrombus growth and stability. To date, the relative importance of these two immunoreceptor tyrosine-based activation motif-bearing receptors in these processes remains unknown. Objective The aim of this study was to evaluate the relative contributions of FcγRIIA and GPVI to platelet activation on fibrinogen and subsequent thrombus growth and stability. Methods We evaluated human and mouse platelet adhesion to fibrinogen in static assays and a flow-based approach to evaluate the contribution of FcγRIIA and GPVI to thrombus growth and stability. Results We first confirmed that integrin αIIbβ3 is the key receptor supporting platelet adhesion and spreading on fibrinogen. Using human platelets treated with pharmacological blocking agents and transgenic mouse platelets expressing human receptors, data indicate that GPVI, but not FcγRIIA, plays a prominent role in platelet activation on fibrinogen. Moreover, using a flow-based assay, we observed that blockade of GPVI with 1G5, but not FcγRIIA with IV.3, prevents thrombus growth. Finally, we observed that 1G5, but not IV.3, promotes the disaggregation of thrombi formed on collagen in vitro. Conclusion This study provides evidence that GPVI, but not FcγRIIA, induces platelet activation and spreading on fibrinogen, and promotes thrombus buildup and stability.
机译:背景技术血小板和纤维蛋白原之间的相互作用是血栓形成的基石。整合素αIIBβ3是用于纤维蛋白原的主要血小板粘附受体,并在加强血小板活化的配体结合时介导外部信号。此外,FCγRIIA和糖蛋白VI(GPVI)有助于纤维蛋白原的血小板活化,从而参与血栓生长和稳定性。迄今为止,这些过程中,这两个免疫受菌酪氨酸的活化基序受体的相对重要性仍然未知。目的本研究的目的是评估FCγRIIA和GPVI对纤维蛋白原和随后的血栓生长和稳定性的血小板活化的相对贡献。方法,我们评估了静态测定中的人和小鼠血小板粘附和静态测定中的纤维蛋白原和基于流动的方法来评估FcγRIIA和GPVI与血栓生长和稳定性的贡献。结果我们首先证实,整合蛋白αiibβ3是支持血小板粘附和纤维蛋白原散布的关键受体。使用用药物阻断剂治疗的人血小板和表达人受体的转基因小鼠血小板,数据表明GPVI但不是FCγRIIA在纤维蛋白原上的血小板活化中起着突出的作用。此外,使用基于流动的测定,我们观察到具有1G5的GPVI阻断,但不是具有IV.3的FcγRIIA,可防止血栓生长。最后,我们观察到1G5但不是IV.3,促进了在体外胶原蛋白形成的血栓的分解。结论本研究规定了GPVI,但不是FCγRIIA,诱导血小板活化和在纤维蛋白原上传播,并促进血栓累积和稳定性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号